Description: Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in Latin America and, as of December 31, 2020, had more than 4,700 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions.
Home Page: www.procapsgroup.com
PROC Technical Analysis
9 Rue de Bitbourg
Luxembourg City,
1273
Luxembourg
Phone:
356 7995 6138
Officers
| Name | Title |
|---|---|
| Mr. Ruben Minski | Founder, CEO & Chairman |
| Dr. Camilo Camacho | Pres |
| Mr. Patricio Vargas Munoz | Global Chief Financial Officer |
| Ms. Melissa Angelini | Investor Relations Director |
| Ms. Marcela Carvajalino Pagano | Vice-Pres of Corp. & Legal Affairs |
| Mr. Luis Alberto Palacios Aragon | Vice-Pres of International Marketing and R&D |
| Mr. Mauricio Castaneda Caballero | Vice-Pres of HR |
| Mr. Carlos Piocuda Russo | Head of Optimization of Corp. Value & Corp. VP of Fin. |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 13.2979 |
|---|---|
| Trailing PE: | 8.6034 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.6081 |
| IPO Date: | 2021-09-30 |
| Fiscal Year End: | December |
| Full Time Employees: | 5300 |